127 related articles for article (PubMed ID: 21447610)
1. Transgenic animal models in toxicology: historical perspectives and future outlook.
Boverhof DR; Chamberlain MP; Elcombe CR; Gonzalez FJ; Heflich RH; Hernández LG; Jacobs AC; Jacobson-Kram D; Luijten M; Maggi A; Manjanatha MG; Benthem Jv; Gollapudi BB
Toxicol Sci; 2011 Jun; 121(2):207-33. PubMed ID: 21447610
[TBL] [Abstract][Full Text] [Related]
2. The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives.
Blaauboer BJ
Toxicol Lett; 2008 Aug; 180(2):81-4. PubMed ID: 18586419
[TBL] [Abstract][Full Text] [Related]
3. Identification and hepatic expression profiles of cytochrome P450 1-4 isozymes in common minke whales (Balaenoptera acutorostrata).
Niimi S; Kim EY; Iwata H; Watanabe MX; Yasunaga G; Fujise Y; Tanabe S
Comp Biochem Physiol B Biochem Mol Biol; 2007 Aug; 147(4):667-81. PubMed ID: 17526421
[TBL] [Abstract][Full Text] [Related]
4. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
[TBL] [Abstract][Full Text] [Related]
5. Safety assessment of drug metabolites: implications of regulatory guidance and potential application of genetically engineered mouse models that express human P450s.
Powley MW; Frederick CB; Sistare FD; DeGeorge JJ
Chem Res Toxicol; 2009 Feb; 22(2):257-62. PubMed ID: 19170595
[TBL] [Abstract][Full Text] [Related]
6. Toxicology in the 21st century--working our way towards a visionary reality.
Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
[TBL] [Abstract][Full Text] [Related]
7. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
[TBL] [Abstract][Full Text] [Related]
8. Involvement of various molecular events in cellular injury induced by smokeless tobacco.
Avti PK; Vaiphei K; Pathak CM; Khanduja KL
Chem Res Toxicol; 2010 Jul; 23(7):1163-74. PubMed ID: 20521779
[TBL] [Abstract][Full Text] [Related]
9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
10. Naphthalene toxicity in mice and aryl hydrocarbon receptor-mediated CYPs.
Genter MB; Marlowe J; Kevin Kerzee J; Dragin N; Puga A; Dalton TP; Nebert DW
Biochem Biophys Res Commun; 2006 Sep; 348(1):120-3. PubMed ID: 16876762
[TBL] [Abstract][Full Text] [Related]
11. Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR.
Zhang J; Huang W; Chua SS; Wei P; Moore DD
Science; 2002 Oct; 298(5592):422-4. PubMed ID: 12376703
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics of the human cytochrome P450 monooxygenase superfamily.
Smith G; Stubbins MJ; Harries LW; Wolf CR
Xenobiotica; 1998 Dec; 28(12):1129-65. PubMed ID: 9890157
[No Abstract] [Full Text] [Related]
13. Ontogeny of hepatic CYP1A2 and CYP2E1 expression in rat.
Elbarbry FA; McNamara PJ; Alcorn J
J Biochem Mol Toxicol; 2007; 21(1):41-50. PubMed ID: 17366540
[TBL] [Abstract][Full Text] [Related]
14. Transgenic rice plants expressing human p450 genes involved in xenobiotic metabolism for phytoremediation.
Kawahigashi H; Hirose S; Ohkawa H; Ohkawa Y
J Mol Microbiol Biotechnol; 2008; 15(2-3):212-9. PubMed ID: 18685273
[TBL] [Abstract][Full Text] [Related]
15. Transgenic rodents in toxicology.
Dayan AD
Int J Exp Pathol; 1996 Dec; 77(6):251-6. PubMed ID: 9155658
[No Abstract] [Full Text] [Related]
16. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
17. Toxicity testing in the 21st century: how will it affect risk assessment?
Rhomberg LR
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
[TBL] [Abstract][Full Text] [Related]
18. The future of toxicity testing.
Andersen ME; Al-Zoughool M; Croteau M; Westphal M; Krewski D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):163-96. PubMed ID: 20574896
[TBL] [Abstract][Full Text] [Related]
19. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
20. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
